Centrum 7/6  banner

Issues

Health care outlook 2024: Peter Matz, director of Food, Pharmacy and Health Policy at FMI – The Food Industry Association

Health care outlook 2024: Peter Matz, director of Food, Pharmacy and  Health Policy at FMI – The Food  Industry Association

In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. Up until a few years ago, when meeting with lawmakers to advocate for pharmacy benefit manager reform measures, we typically

Health care outlook 2024: Michael Hogue, CEO, APhA

Health care outlook 2024: Michael Hogue, CEO, APhA

In the first of a two-part series, leaders of industry associations present their expectations for pharmacy operators for this year. The views of other organizations will appear in the next issue of Chain Drug Review. As the oldest national professional association for pharmacists, pharmacy technicians, student pharmacists and pharmaceutical scientists, the American Pharmacists Association touches

The shifting profit pie: How earnings across the pharma sector are changing

The shifting profit pie: How earnings across the pharma sector are changing

How is the pharmaceutical value chain faring financially? Who are the biggest winners and losers? Every two years, Kearney analyzes pharmaceutical profit pools to answer those questions. Our analysis follows a drug across the value chain, from concept to patient. We aim to understand the profitability of key players in the U.S. value chain and

Special section celebrates NACDS’ 90th anniversary

Special section celebrates NACDS’ 90th anniversary

Read the December 11th issue of Chain Drug Review, which includes a special section commemorating the 90th anniversary of the founding of the National Association of Chain Drug Stores. The 56-page section is presented by CDR, Drug Store News and the Emerson Group.  Here is the link for the issue:  http://digitaledition.chaindrugreview.com/publication/?i=809929. The section begins on page

Don’t be late to celebrate NACDS’ 90th anniversary

Don’t be late to celebrate NACDS’ 90th anniversary

This is an especially special holiday season for participants in and advocates of chain drug retailing in America. Reason? The season celebrates and pauses to recall the 90th anniversary of the National Association of Chain Drug Stores. Much has been written over the years, in this publication and others, lauding the indispensable impact NACDS has

Dr. Reddy’s Balasubramanian on growth engines

Dr. Reddy’s Balasubramanian on growth engines

Dinakaran (Dina) Balasubramanian, head of commercial strategy and insights for biologics at Dr. Reddy’s Laboratories, spoke with Chain Drug Review about his role at the drug maker and how specialty generic drugs and biosimilars are fueling growth for it. CDR: What are your responsibilities now with Dr. Reddy’s ­Laboratories? BALASUBRAMANIAN: One of my primary responsibilities

Efficiency and health equity can align powerfully

Efficiency and health equity can align powerfully

With growing disparities in health outcomes, health care leaders know that it’s important to continue working toward new solutions to improve health equity. But amid ongoing cost pressures and continued labor shortages, addressing health equity can get lost along the way. So, how do we ensure health equity remains a central priority for pharmacy retailers?

Pipeline Digest meets specialty drug market needs

Pipeline Digest meets specialty drug market needs

When AscellaHealth released its Q3 2023 Specialty & Rare Pipeline Digest, an expert resource for FDA approval status of specialty pharmaceuticals and cell and gene therapies (CGT), this complimentary, digital source of industry information elevated support for the specialty drug market needs of all stakeholders and decision makers, including pharmaceutical manufacturers, payers, providers and retail

Shared-resource model keeps supply chain flowing

Shared-resource model keeps supply chain flowing

It’s no secret that the supply chain still faces challenges stemming from the COVID-19 pandemic. Even with the public health emergency declared over in May, some supply chain disruptions persist. Thankfully, improved pharmaceutical distribution and transportation solutions can lessen that burden. Across the pharmaceutical industry the goal has been to reduce costs, improve efficiency and

Harnessing AI to overcome next year’s DIR hurdle

Harnessing AI to overcome next year’s DIR hurdle

It’s no secret that pharmacies and the health care professionals that staff them are under extreme pressure. Pharmacies face a daily challenge in keeping up with prescription demand, as they contend with shrinking profits and a diminishing number of staff willing to endure the demanding workload. Pharmacies are caught in a frustrating race, tirelessly running

Panel: Facial products, especially for acne, driving skin care market

Panel: Facial products, especially for acne, driving skin care market

AUSTIN, Texas — The $16.8 billion skin care category is one of the fastest-growing across the beauty industry, according to exclusive data presented by Circana at the third annual Dermatology and Retail Alliance. Facial skin care drives sales in the mass market in both dollars and units at a time when gains in many categories

PP_1170x120_10-25-21